Phase I study of ON 01910.Na by 3-day continuous infusion (CI) in patients (pts) with advanced cancer
T Ohnuma(Temple University), E. Premkumar Reddy(The Graduate Center, CUNY), Jian‐Dong Jiang(Ningbo University), John Roboz(Temple University), Deborah Lehrer(Temple University), Jonathan D. Schwartz(Temple University), L. B. Silverman(Kettering University), S. Y. Cho(Temple University)
Cited by 17
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides
|Nature|1992|689
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
|Liver Transplantation|2004|464